1
|
Burgio N, Cretara L, Corcione M, Frullini M, Iannascoli L, Nascetti A, Santagata A, Palmerini G, Quintino A, Brucato JR, Meneghin A, Paglialunga D. Modelling the interaction of the Astro Bio Cube Sat with the Van Allen’s Belt radiative field using Monte Carlo transport codes. Radiat Detect Technol Methods 2022. [DOI: 10.1007/s41605-022-00321-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Abstract
Purpose
The AstroBio Cube Satellite (ABCS) will deploy within the inner Van Allen belt on the Vega C Maiden Flight launch opportunity of the European Space Agency. At this altitude, ABCS will experience radiation doses orders of magnitude greater than in low earth orbit, where CubeSats usually operate. The paper aims to estimate the irradiation effect on the ABCS payload in the orbital condition, their possible mitigation designing shielding solutions and performs a preliminary representativity simulation study on the ABCS irradiation with fission neutron at the TAPIRO (TAratura Pila Rapida Potenza 0) nuclear research reactor facility at ENEA.
Methods
We quantify the contributions of geomagnetically trapped particles (electron and proton), Galactic Cosmic Rays (GCR ions), Solar energetic particle within the ABCS orbit using the ESA’s SPace ENVironment information system. FLUKA (Fluktuierende Kaskade—Fluctuating Cascade) code models the ABCS interaction with the orbital source.
Results
We found a shielding solution of the weight of 300 g constituted by subsequent layers of tungsten, resins, and aluminium that decreases on average the 20% overall dose rate relative to the shielding offered by the only satellite’s structure. Finally, simulations of neutron irradiation of the whole ABCS structure within the TAPIRO’s thermal column cavity show that a relatively short irradiation time is requested to reach the same level of 1 MeV neutron Silicon equivalent damage of the orbital source.
Conclusions
The finding deserves the planning of a future experimental approach to confirm the TAPIRO’s performance and establish an irradiation protocol for testing aerospatial electronic components.
Collapse
|
2
|
Salvatores M, Orsitto F, Carta M, Burgio N, Fabrizio V, Falconi L, Palomba M, Panza F. An approach to the experimental validation of the fission multiplying blanket of hybrid fusion fission systems. ANN NUCL ENERGY 2021. [DOI: 10.1016/j.anucene.2020.108055] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
3
|
Abstract
Aim Portable cameras allow easy transfer of the detector, and thus of radioisotope imaging, to the operating room. In this paper we describe our preliminary experience in radionuclide imaging of breast cancer with a 22.8 × 22.8 mm2 field-of-view minicamera called “Imaging Probe” (IP). Methods Breast cancer detection by IP was performed to guide biopsy, in particular open biopsy, or help fine-needle or core-needle positioning when the main guidance method was ultrasonography or digital radiography. 99mTc Sestamibi (MIBI) was injected 1 h before imaging and biopsy to 14 patients with suspected or known breast cancer. Scintigraphic images were acquired before and after biopsy in each patient. The surgeon was allowed to take into account scintigraphic images as well as previously performed mammograms and ultrasonography. Results High-resolution IP images were able to guide biopsy toward cancer or toward washout zones of cancer, which are thought to be chemoresistant, in seven patients out of 10. Four patients in whom IP and MIBI were unable to guide biopsy were found not to have cancer. Conclusions Our study confirms the ability of IP to guide breast biopsy even when our minicamera has to be handled manually by trained physicians during surgery.
Collapse
Affiliation(s)
- R Scafè
- ENEA-CR Casaccia, Rome, Italy
| | | | | | | | | | | | | | | |
Collapse
|
4
|
D'Errico G, Rosa MA, Soluri A, Scafè R, Galli M, Chiarini S, Burgio N, Schiaratura A, Massa R, Scopinaro F. Radioguided Biopsy of Osteoid Osteoma: Usefulness of Imaging Probe. Tumori 2018; 88:S30-2. [PMID: 12365380 DOI: 10.1177/030089160208800333] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Aims and Background When removal of osteoid osteoma is performed with open biopsy, the surgeon can be guided by radioactivity of 99mTc-MDP (methylene D- phosphonate) acquired by a probe. Material and methods We compared the performance of a commercially available ZnCdTe probe (Neoprobe 2000) and a one-square-inch-field-of-view imaging probe (IP) on two patients undergoing open biopsy for osteoid osteoma. Triphasic bone scintigraphy was performed before operation and Neoprobe as well as IP were used in the operating room by two nuclear physicians. When the surgeon asked for guidance, each nuclear physician had to indicate a precise direction. Results The surgeon asked for guidance once in the first operation, on a patient with osteoid osteoma of the femur, and four times in the second operation, for osteoid osteoma of the acetabulum. The indications provided by IP were correct 5/5 times, whereas the commercial probe was correct 3/5 times. Both devices were able to assess the surgical radicality. After biopsy, bone samples were divided into high-count and low-count samples. Pathological examination confirmed the presence of osteoid osteoma in high-count samples. Conclusions IP has already been used to guide biopsy, but only in breast disease. The present work confirms its good performance also in orthopedics as a portable mini gamma camera that can be used in the operating room.
Collapse
Affiliation(s)
- G D'Errico
- Catholic University Sacro Cuore, Rome, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Soluri A, Scafè R, Falcini F, Sala R, Burgio N, Stella S, David V, Scopinaro F. New Localization Technique for Breast Cancer Biopsy: Mammotome Guidance with Imaging Probe. Tumori 2018; 88:S37-9. [PMID: 12365383 DOI: 10.1177/030089160208800336] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Aims and Background The “Imaging probe” (IP) is a small, portable, high-resolution gamma camera to be used in radioguided surgery. The present work discusses a special prototype designed for guiding biopsies. The IP was mounted to a Fischer digital X-ray stereotactic core biopsy system in such a way that biopsy could be guided simultaneously by X-ray stereotaxis and 99mTc-Sestamibi (MIBI) images from IP. Methods The IP field of view was 22.8 × 22.8 mm2, with a spatial resolution of approx. 2.5 mm. We used off-line software for image fusion on a dedicated Pentium III portable PC. It was matched with a Fischer digital X-ray stereotactic biopsy system dedicated to direct the mammotome towards breast opacities. The operator was allowed to slightly correct the direction of the mammotome needle taking into account stereotactic X-ray, scintigraphic and fused images. Biopsy samples were counted by IP before they were sent to the pathologist. Results High-resolution IP scintigraphy showed substantial, though not exact, matching between MIBI hot spots and X-ray opacities. More than one hot spot was detected even in the smallest (0.6 cm) lesion. Post-biopsy scintigraphy showed absence of significant hot spots in two patients, whereas in the third patient one of the three hot spots was still partially present. All lesions showed cancer on histological examination. Conclusions Measurement of radioactivity in biopsy specimens confirmed the heterogeneous distribution of radioactivity within cancers that IP had detected before biopsy.
Collapse
Affiliation(s)
- A Soluri
- Institute of Biomedical Technologies, CNR, Rome
| | | | | | | | | | | | | | | |
Collapse
|
6
|
Schillaci O, D'Errico G, Scafè R, Soluri A, Burgio N, Santagata A, Spanu A, Mangano AM, David V, Schiaratura A, Scopinaro F. Sentinel Node Detection with Imaging Probe. Tumori 2018; 88:S32-5. [PMID: 12365381 DOI: 10.1177/030089160208800334] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
A one-square-inch-field-of-view mini gamma camera, whose first prototype was built by us in 1998 and given the name imaging probe (IP), was initially employed in sentinel lymph node (SLN) detection. This is probably the best way of learning how to use it. In the present work IP was used for SLN localization by a medical team that, after having been trained by the group of nuclear physicians of “La Sapienza” University who designed and first used the detector, used IP at their own hospital to 1) acquire experience for future use during surgery (a cooperative project on IP-radioguided orthopedic surgery is ongoing) and 2) start multicenter trials with IP. The SLN was identified and localized with IP and a non-imaging probe, Neoprobe 2000, in six patients with breast cancer who underwent lymphoscintigraphy for SLN biopsy. The operators who used Neoprobe and IP were blinded to each other's findings and to the results obtained with the large-field-of-view Anger camera that was used for lymphoscintigraphy. The Anger camera, IP and Neoprobe detected seven SLNs in six patients. The mean detection time was 2 mins 6 s (standard deviation (SD) 26 s) with IP, and 2 mins 18 s (SD 47 s) with Neoprobe 2000. The SLN that was most difficult to find was detected in 2 mins 56 s with IP and 3 mins 45 s with Neoprobe. The operators' subjective impression of having detected the SLN was “absolutely sure” for 7/7 nodes with IP and “absolutely sure” for 5/7 nodes with Neoprobe.
Collapse
|
7
|
Rubbia C, Carta M, Burgio N, Ciavola C, D’Angelo A, Dodaro A, Festinesi A, Monti S, Santagata A, Troiani F, Salvatores M, Delpech M, Kadi Y, Buono S, Ferrari A, Martínez AH, Zanini L, Imel G. Neutronic Analyses of the Trade Demonstration Facility. NUCL SCI ENG 2017. [DOI: 10.13182/nse04-a2445] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- C. Rubbia
- ENEA/Ente per le Nuove Tecnologie, l’Energia e l’Ambiente Lungotevere Thaon di Revel 76-00196 Rome, Italy
| | - M. Carta
- ENEA/Ente per le Nuove Tecnologie, l’Energia e l’Ambiente Lungotevere Thaon di Revel 76-00196 Rome, Italy
| | - N. Burgio
- ENEA/Ente per le Nuove Tecnologie, l’Energia e l’Ambiente Lungotevere Thaon di Revel 76-00196 Rome, Italy
| | - C. Ciavola
- ENEA/Ente per le Nuove Tecnologie, l’Energia e l’Ambiente Lungotevere Thaon di Revel 76-00196 Rome, Italy
| | - A. D’Angelo
- ENEA/Ente per le Nuove Tecnologie, l’Energia e l’Ambiente Lungotevere Thaon di Revel 76-00196 Rome, Italy
| | - A. Dodaro
- ENEA/Ente per le Nuove Tecnologie, l’Energia e l’Ambiente Lungotevere Thaon di Revel 76-00196 Rome, Italy
| | - A. Festinesi
- ENEA/Ente per le Nuove Tecnologie, l’Energia e l’Ambiente Lungotevere Thaon di Revel 76-00196 Rome, Italy
| | - S. Monti
- ENEA/Ente per le Nuove Tecnologie, l’Energia e l’Ambiente Lungotevere Thaon di Revel 76-00196 Rome, Italy
| | - A. Santagata
- ENEA/Ente per le Nuove Tecnologie, l’Energia e l’Ambiente Lungotevere Thaon di Revel 76-00196 Rome, Italy
| | - F. Troiani
- ENEA/Ente per le Nuove Tecnologie, l’Energia e l’Ambiente Lungotevere Thaon di Revel 76-00196 Rome, Italy
| | - M. Salvatores
- Commissariat à l’Energie Atomique/Cadarache, Direction de l’Energie Nucléaire 13108 Saint-Paul-Lez-Durance, France
| | - M. Delpech
- Commissariat à l’Energie Atomique/Cadarache, Direction de l’Energie Nucléaire 13108 Saint-Paul-Lez-Durance, France
| | - Y. Kadi
- CERN/European Organization for Nuclear Research, CH - 1211 Geneva 23, Switzerland
| | - S. Buono
- CERN/European Organization for Nuclear Research, CH - 1211 Geneva 23, Switzerland
| | - A. Ferrari
- CERN/European Organization for Nuclear Research, CH - 1211 Geneva 23, Switzerland
| | - A. Herrera Martínez
- CERN/European Organization for Nuclear Research, CH - 1211 Geneva 23, Switzerland
| | - L. Zanini
- CERN/European Organization for Nuclear Research, CH - 1211 Geneva 23, Switzerland
| | - G. Imel
- Argonne National Laboratory-West, P.O. Box 2528, Idaho Falls, Idaho 83403
| |
Collapse
|
8
|
Burgio N, Cretara L, Frullini M, Gandini A, Peluso V, Santagata A. Monte Carlo simulation analysis of integral data measured in the SCK-CEN/ENEA experimental campaign on the TAPIRO fast reactor. Experimental and calculated data comparison. Nuclear Engineering and Design 2014. [DOI: 10.1016/j.nucengdes.2014.03.040] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
9
|
Maciocco L, Avila S, Buono S, Burgio N, Haddad F, Abbas K. 285 EXPERIMENTAL QUALIFICATION OF THE THERANEAN ACCELERATOR-DRIVEN NEUTRON ACTIVATOR FOR THE PRODUCTION OF ACTIVATED NANOPARTICLES FOR CANCER TREATMENT. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)70248-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
10
|
Gibson N, Holzwarth U, Abbas K, Simonelli F, Kozempel J, Cydzik I, Cotogno G, Bulgheroni A, Gilliland D, Ponti J, Franchini F, Marmorato P, Stamm H, Kreyling W, Wenk A, Semmler-Behnke M, Buono S, Maciocco L, Burgio N. Radiolabelling of engineered nanoparticles for in vitro and in vivo tracing applications using cyclotron accelerators. Arch Toxicol 2011; 85:751-73. [DOI: 10.1007/s00204-011-0701-6] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2010] [Accepted: 03/23/2011] [Indexed: 12/28/2022]
|
11
|
Buono S, Burgio N, Hamoudeh M, Fessi H, Hiltbrand E, Maciocco L, Mehier-Humbert S. Brachytherapy: State of the Art and Possible Improvements. Anticancer Agents Med Chem 2007; 7:411-24. [PMID: 17630917 DOI: 10.2174/187152007781058640] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Cancer often remains an incurable disease, despite significant progresses in diagnosis and treatment that have been made. Specifically, the use of nuclear medicine in oncology is greatly contributing to both imaging and therapy aspects. Targeted therapies are a major field of interest since it increases efficiency and reduces side effects. Brachytherapy is among the most valuable of recent developments for treating localized tumours resulting in improvements in improved quality of life. This is primarily because it irradiates cancerous cells most exclusively while barely effecting healthy tissue. The use of radiochemicals implies specific management for production, transport and handling that have limited the development of this technique. This review article describes brachytherapy and their latest developments. Furthermore, alternative activation methods for the production of radioisotopes and a novel delivery system for targeted multi-therapy by using PLA-ferrite nanospheres are described.
Collapse
Affiliation(s)
- S Buono
- Advanced Accelerator Applications, Saint-Genis Pouilly, France
| | | | | | | | | | | | | |
Collapse
|
12
|
Abstract
The TRIGA RC-1 1MW reactor operating at ENEA Casaccia Center is currently being developed as a second neutron imaging facility that shall be devoted to computed tomography as well as neutron tomography. In order to reduce the gamma-ray content in the neutron beam, the reactor tangential piercing channel was selected. A set of Monte Carlo simulation was used to design the neutron collimator, to determine the preliminary choice of the materials to be employed in the collimator design.
Collapse
Affiliation(s)
- N Burgio
- ENEA--Casaccia Research Centre, Via Anguillarese, 301, S. Maria Di Galeria, Roma 00060 S, Italy
| | | |
Collapse
|
13
|
Burgio N, Capannesi G, Ciavola C, Sedda AF. The use of a radioactive tracer for the determination of distillation end point in a coke oven. J Radioanal Nucl Chem 1995. [DOI: 10.1007/bf02036544] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
14
|
Padella F, Paradiso E, Burgio N, Magini M, Martelli S, Guo W, Iasonna A. Mechanical alloying of the Pd-Si system in controlled conditions of energy transfer. ACTA ACUST UNITED AC 1991. [DOI: 10.1016/0022-5088(91)90351-4] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|